tiprankstipranks
Trending News
More News >
VETOQUINOL (FR:VETO)
:VETO

VETOQUINOL (VETO) Price & Analysis

Compare
4 Followers

VETO Stock Chart & Stats


Bulls Say, Bears Say

Bulls Say
Earnings GrowthVetoquinol's adjusted EBIT has returned to growth for the first time in 3 years, marking the start of a positive upturn.
Financial PerformanceThe company's high gross margin and strong financial resources are expected to accelerate EPS growth.
Bears Say
Potential DelistingThe group has a net cash position of at least €150m, representing firepower of €450m, which may incentivize the majority shareholder to attempt to delist the company if the strong discount persists.

Financials

Options Prices

Currently, No data available
---

Ownership Overview

4.14%95.81%
Insiders
4.14%
Mutual Funds
― Other Institutional Investors
95.81% Public Companies and
Individual Investors

VETO FAQ

What was VETOQUINOL’s price range in the past 12 months?
VETOQUINOL lowest stock price was €63.60 and its highest was €102.80 in the past 12 months.
    What is VETOQUINOL’s market cap?
    VETOQUINOL’s market cap is €903.52M.
      When is VETOQUINOL’s upcoming earnings report date?
      VETOQUINOL’s upcoming earnings report date is Sep 11, 2025 which is in 66 days.
        How were VETOQUINOL’s earnings last quarter?
        VETOQUINOL released its earnings results on Mar 20, 2025. The company reported €2.956 earnings per share for the quarter, beating the consensus estimate of N/A by €2.956.
          Is VETOQUINOL overvalued?
          According to Wall Street analysts VETOQUINOL’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does VETOQUINOL pay dividends?
            VETOQUINOL pays a Annually dividend of €0.772 which represents an annual dividend yield of 1.01%. See more information on VETOQUINOL dividends here
              What is VETOQUINOL’s EPS estimate?
              VETOQUINOL’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does VETOQUINOL have?
              VETOQUINOL has 11,881,902 shares outstanding.
                What happened to VETOQUINOL’s price movement after its last earnings report?
                VETOQUINOL reported an EPS of €2.956 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.224%.
                  Which hedge fund is a major shareholder of VETOQUINOL?
                  Currently, no hedge funds are holding shares in FR:VETO

                  Company Description

                  VETOQUINOL

                  Vetoquinol SA, a veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region. It provides products in the areas of mobility, pain, and inflammation; dermatology, hygiene, and care; anti-parasite; udder health; infectious diseases; reproduction; behavior management; internal medicine; and cardiology-nephrology for cattle, sheep, pigs, poultry, and dogs. The company was founded in 1933 and is headquartered in Lure, France. Vetoquinol SA is a subsidiary of Soparfin SCA.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Boiron SA
                  Ipsen
                  Valneva
                  Virbac SA
                  MedinCell SA
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis